Safety and Tolerance of RAG-17 in Amyotrophic Lateral Sclerosis Patients With SOD1 Gene Mutation
Clinical trial NCT05903690 · COMPLETED
Trial details
- NCT number
- NCT05903690
- Sponsor
- Beijing Tiantan Hospital
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-24
- Primary completion
- 2024-07-11
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.